Hot Stocks
|
Ovid Therapeutics (OVID)… ShowHide Related Items >><< - 01/05/23
- Ovid Therapeutics dosed healthy volunteers with OV329 in Phase 1 trial
- 12/02/22
- Ovid Therapeutics to present data on epilepsy programs at AES Meeting
- 08/09/22
- Ovid Therapeutics sees cash runway into 2025
- 08/29/22 Citi
- Ovid Therapeutics price target raised to $2.50 from $2.40 at Citi
- 11/08/22
- Ovid Therapeutics reports Q3 EPS (17c), consensus (21c)
- 08/09/22
- Ovid Therapeutics reports Q2 EPS (21c) vs. (23c) last year
|
Hot Stocks
|
Element Biosciences, the… ShowHide Related Items >><< - 02/07/23
- Cytek Biosciences partners with Bio-Rad to expand reagent portfolios
- 02/06/23
- Singular Genomics showcases G4 sequencing data with 11 genomics partners
- 10/10/22
- Qiagen up 5%, Bio-Rad down 6% following WSJ report on talks to combine
- 12/06/22 RBC Capital
- Bio-Rad initiated with an Outperform at RBC Capital
- 10/11/22 Jefferies
- Jefferies 'not surprised' by report of Bio-Rad talks to combine with Qiagen
- 08/24/22 Credit Suisse
- Bio-Rad initiated with an Outperform at Credit Suisse
- 07/08/22 Citi
- Bio-Rad price target lowered to $700 from $750 at Citi
- 10/27/22
- Bio-Rad sees FY22 non-GAAP currency-neutral revenue growth at high end of 1%-2%
- 10/27/22
- Bio-Rad reports Q3 EPS $2.60, consensus $2.78
- 10/10/22
- Bio-Rad in talks to combine with Qiagen in deal worth more than $10B, WSJ says
- 10/10/22
- Bio-Rad in talks to combine with Qiagen, WSJ reports
- 12/17/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 10/10/22
- What You Missed On Wall Street On Monday
- 01/26/23
- Early notable gainers among liquid option names on January 26th
- 01/11/23
- Early notable gainers among liquid option names on January 11th
|
Hot Stocks
| ShowHide Related Items >><< - 08:08 Today
- Uber 'really focused' on efficiency
- 08:06 Today
- Uber: Uber One a 'terrific' membership program
- 07:42 Today
- Uber saw 'strong' top-line trends in January, strength in Mobility and Delivery
- 07:41 Today
- Uber entering the year with 'great momentum,' says CEO
- 01/31/23 Mizuho
- Mizuho 'constructive' on Uber shares into Q4 results
- 01/30/23 MoffettNathanson
- Uber initiated with an Outperform at MoffettNathanson
- 01/26/23 Cowen
- Uber price target lowered to $66 from $70 at Cowen
- 01/24/23 KeyBanc
- KeyBanc upgrades Lyft on 'meaningful opportunity' for EBITDA lift
- 06:59 Today
- Uber reports Q4 EPS 29c, consensus (18c)
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Uber reports Q3 EPS (61c), consensus (22c)
- 01/26/23
- NYC to require Uber and Lyft to be zero emission by 2030, Verge says
- 01/24/23
- Uber Freight laid off 150 workers on Monday, CNBC reports
- 01/19/23
- Uber working to design lower cost EVs customized for ride sharing, WSJ reports
- 01/12/23
- Uber drivers struggle to live off their earnings, NY Times reports
- 02/04/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/19/23
- What You Missed On Wall Street On Thursday
- 01/19/23
- What You Missed On Wall Street This Morning
- 02/01/23
- Uber call volume above normal and directionally bullish
- 01/26/23
- Uber call volume above normal and directionally bullish
- 01/09/23
- Data confirms customer adding to massive short-term downside hedge in Uber
- 12/22/22
- Uber put volume heavy and directionally bearish
|
Hot Stocks
| ShowHide Related Items >><< - 08:06 Today
- Uber: Uber One a 'terrific' membership program
- 07:42 Today
- Uber saw 'strong' top-line trends in January, strength in Mobility and Delivery
- 07:41 Today
- Uber entering the year with 'great momentum,' says CEO
- 07:02 Today
- Uber up 7% in pre-market trading after Q4 report
- 01/31/23 Mizuho
- Mizuho 'constructive' on Uber shares into Q4 results
- 01/30/23 MoffettNathanson
- Uber initiated with an Outperform at MoffettNathanson
- 01/26/23 Cowen
- Uber price target lowered to $66 from $70 at Cowen
- 01/24/23 KeyBanc
- KeyBanc upgrades Lyft on 'meaningful opportunity' for EBITDA lift
- 06:59 Today
- Uber reports Q4 EPS 29c, consensus (18c)
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Uber reports Q3 EPS (61c), consensus (22c)
- 01/26/23
- NYC to require Uber and Lyft to be zero emission by 2030, Verge says
- 01/24/23
- Uber Freight laid off 150 workers on Monday, CNBC reports
- 01/19/23
- Uber working to design lower cost EVs customized for ride sharing, WSJ reports
- 01/12/23
- Uber drivers struggle to live off their earnings, NY Times reports
- 02/04/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/19/23
- What You Missed On Wall Street On Thursday
- 01/19/23
- What You Missed On Wall Street This Morning
- 02/01/23
- Uber call volume above normal and directionally bullish
- 01/26/23
- Uber call volume above normal and directionally bullish
- 01/09/23
- Data confirms customer adding to massive short-term downside hedge in Uber
- 12/22/22
- Uber put volume heavy and directionally bearish
|
Hot Stocks
| ShowHide Related Items >><< - 01/31/23
- Sysco making 'solid' progress on CFO search
- 01/31/23
- Sysco: 'Strong' start to January volume performance
- 12/21/22
- Guest Supply, Innvision Hospitality partner for interior design services
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 02/02/23 Argus
- Argus cuts Sysco to Hold amid rising product and labor costs
- 02/02/23 Argus
- Sysco downgraded to Hold from Buy at Argus
- 02/01/23 BMO Capital
- Sysco price target lowered to $90 from $96 at BMO Capital
- 02/01/23 Barclays
- Sysco price target lowered to $87 from $92 at Barclays
- 01/31/23
- Sysco sees FY23 EPS $4.00-$4.15, consensus
- 01/31/23
- Sysco reports Q2 adjusted EPS 80c, consensus 84c
- 11/01/22
- Sysco reaffirms FY23 guidance, including adjusted EPS $4.09-$4.39
- 11/01/22
- Sysco reports Q1 adjusted EPS 97c, consensus 99c
- 10/27/22
- DOJ investigating how poultry companies pay farmers, WSJ reports
- 02/02/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/31/23
- What You Missed On Wall Street This Morning
- 11/01/22
- What You Missed On Wall Street On Tuesday
- 01/31/23
- Unusually active option classes on open January 31st
- 11/30/22
- Largest borrow rate increases among liquid names
|
Hot Stocks
| ShowHide Related Items >><< RYTM Rhythm Pharmaceuticals - 01/23/23
- Rhythm Pharmaceuticals announces HRQOL improvement from Phase 3 trial in BBS
- 01/10/23
- Amarin appoints Stewart to board of directors
- 11/21/22
- Rhythm announce Health Canada accepted NDS for setmelanotide
- 11/21/22
- Rhythm announces IMCIVREE granted marketing authorization in Great Britain
RYTM Rhythm Pharmaceuticals - 01/18/23 Canaccord
- Rhythm Pharmaceuticals assumed with a Buy at Canaccord
- 08/07/22 Goldman Sachs
- Rhythm Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
- 08/05/22 BofA
- Rhythm Pharmaceuticals upgraded to Neutral at BofA on strong BBS launch
- 08/05/22 BofA
- Rhythm Pharmaceuticals upgraded to Neutral from Underperform at BofA
RYTM Rhythm Pharmaceuticals - 11/08/22
- Rhythm Pharmaceuticals reports Q3 EPS (79c), consensus ($1.00)
|
Hot Stocks
| ShowHide Related Items >><< - 08:01 Today
- Fox Corp. announces incremental $3B stock repurchase authorization
- 01/31/23
- Tubi signs content deal with Warner Bros. Discovery
- 01/24/23
- Irenic Capital comments on withdrawal of proposal to combine News Corp, Fox
- 01/24/23
- Rupert Murdoch withdrawing proposal for Fox Corp, News Corp. combination
- 08:01 Today
- Fox Corp. announces incremental $3B stock repurchase authorization
- 01/31/23
- Tubi signs content deal with Warner Bros. Discovery
- 01/24/23
- Irenic Capital comments on withdrawal of proposal to combine News Corp, Fox
- 01/24/23
- Rupert Murdoch withdrawing proposal for Fox Corp, News Corp. combination
- 01/31/23 Morgan Stanley
- Fox Corp. resumed with an Equal Weight at Morgan Stanley
- 01/25/23 Loop Capital
- Fox upgraded to Buy with $40 price target at Loop Capital
- 01/25/23 Loop Capital
- Loop upgrades News Corp. to Buy on ending of Fox tie-up
- 01/25/23 Loop Capital
- Fox Corp. upgraded to Buy from Hold at Loop Capital
- 01/31/23 Morgan Stanley
- Fox Corp. resumed with an Equal Weight at Morgan Stanley
- 01/06/23 MKM Partners
- MKM Partners sees WWE as 'very attractive asset' if it goes for sale
- 06/02/22 Wolfe Research
- Fox Corp. assumed at Peer Perform from Outperform at Wolfe Research
- 04/19/22 Rosenblatt
- Fox Corp. initiated with a Neutral at Rosenblatt
- 08:00 Today
- Fox Corp. reports Q2 adjusted EPS 48c, consensus 48c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14
- 08:00 Today
- Fox Corp. reports Q2 adjusted EPS 48c, consensus 48c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14
- 01/31/23
- Warner Bros. Discovery in deals with Roku, Tubi for FAST channels, Reuters says
- 01/24/23
- News Corp. in discussions to sell 80% Move stake to CoStar, FT reports
- 01/13/23
- YouTube testing new hub of free, ad-supported streaming channels, WSJ reports
- 01/04/23
- Fox Corp., News Corp. renew office leases in Manhattan, WSJ reports
- 01/24/23
- News Corp. in discussions to sell 80% Move stake to CoStar, FT reports
- 01/04/23
- Fox Corp., News Corp. renew office leases in Manhattan, WSJ reports
- 10/31/22
- Amazon to challenge ESPN and FS1 with sports talk line-up, NY Post reports
- 10/14/22
- Rupert Murdoch mulls recombining Fox Corp., News Corp., WSJ reports
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/31/23
- What You Missed On Wall Street This Morning
- 01/31/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/25/23
- What You Missed On Wall Street On Wednesday
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/31/23
- What You Missed On Wall Street This Morning
- 01/25/23
- What You Missed On Wall Street On Wednesday
- 01/25/23
- What You Missed On Wall Street This Morning
- 01/25/23
- Early notable gainers among liquid option names on January 25th
|
Downgrade
| ShowHide Related Items >><< - 06:03 Today
- CVS Health to acquire Oak Street Health for $39 per share
- 02/07/23
- Oak Street Health rises 30.0%
- 02/07/23
- Oak Street Health notes policy not to comment on unusual market activity
- 02/07/23
- Oak Street Health rises 31.3%
- 07:42 Today
- CVS Health sees FY23 CapEx $2.8B-$3B
- 07:40 Today
- CVS Health sees FY23 Health Care Benefits revenue $101.4B-$102.9B
- 06:35 Today
- CVS Health sees FY23 cash flow from operations $12.5B-$13.5B
- 06:03 Today
- CVS Health to acquire Oak Street Health for $39 per share
- 07:36 Today Stifel
- Oak Street Health downgraded to Hold from Buy at Stifel
- 02/07/23 Stifel
- Oak Street Health price target raised to $39 from $35 at Stifel
- 02/07/23 Piper Sandler
- Oak Street 'particularly attractive' in current environment, says Piper Sandler
- 01/12/23 Piper Sandler
- Oak Street could be worth over $49 per share in buyout, says Piper Sandler
- 07:36 Today Stifel
- Oak Street Health downgraded to Hold from Buy at Stifel
- 02/07/23 Stifel
- Oak Street Health price target raised to $39 from $35 at Stifel
- 02/07/23 Piper Sandler
- Oak Street 'particularly attractive' in current environment, says Piper Sandler
- 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 01/09/23
- Oak Street Health sees FY23 revenue $3.0B-$3.15B, consensus $3.05B
- 01/09/23
- Oak Street Health raises FY22 revenue view to at or above $2.155B
- 11/07/22
- Oak Street Health reports Q3 EPS (56c), consensus (61c)
- 07:37 Today
- CVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B
- 06:33 Today
- CVS Health reports Q4 adjusted EPS $1.99, consensus $1.92
- 06:05 Today
- CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00
- 06:04 Today
- CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
|
Hot Stocks
|
Gannett (GCI) announced a… ShowHide Related Items >><< - 10/12/22
- Gannett CEO announces 'voluntary severance' offers, other austerity measures
- 08/30/22
- Gambling.com ready for online sports betting launch in Kansas
- 11/17/22 Citi
- Gannett price target raised to $2.10 from $1.70 at Citi
- 08/25/22 Citi
- Gannett price target lowered to $1.70 from $2.65 at Citi
- 07/07/22 Citi
- Gannett price target lowered to $2.65 from $4.25 at Citi
- 11/18/22 Stifel
- Gambling.com price target raised to $12 at Stifel after 'solid' Q3
- 10/25/22 Truist
- Gambling.com price target raised to $12 from $10.50 at Truist
- 08/30/22 Truist
- Gambling.com price target lowered to $10.50 from $12 at Truist
- 11/17/22
- Gambling.com backs FY22 revenue $71M-$76M, consensus $71M
- 11/17/22
- Gambling.com reports Q3 adjusted EPS 16c, two estimates 5c
- 08/29/22
- Gambling.com backs FY22 revenue view $71M-$76M, consensus $71.08M
- 08/29/22
- Gambling.com reports Q2 adjusted EPS 9c vs 8c last year
- 11/17/22
- Fly Intel: After-Hours Movers
- 08/29/22
- Fly Intel: After-Hours Movers
- 10/19/22
- Twelve new option listings and two option delistings on October 19th
|
Hot Stocks
| ShowHide Related Items >><< - 12/15/22
- Astria Therapeutics reports positive Phase 1a results of STAR-0215 in HAE
- 09/02/22
- Astria Therapeutics announces inducement grants under Nasdaq Listing Rule
- 12/19/22 H.C. Wainwright
- Astria Therapeutics price target raised to $20 from $13 at H.C. Wainwright
- 10/05/22 H.C. Wainwright
- H.C. Wainwright has more confidence in Astria opportunity after KalVista news
- 11/10/22
- Astria Therapeutics reports Q3 EPS (87c), consensus (92c)
- 08/09/22
- Astria Therapeutics reports Q2 EPS (86c), consensus ($1.01)
|